Insider Trading February 13, 2026

Insider-Linked Sale: Ford Rollin L’s Spouse Disposes of $3.45M in Symbotic Stock

Trust redemptions and share cancellations accompany a multi-tranche sale as Symbotic posts mixed Q1 FY2026 results

By Priya Menon SYM
Insider-Linked Sale: Ford Rollin L’s Spouse Disposes of $3.45M in Symbotic Stock
SYM

On February 11, 2026, the spouse of Symbotic director Ford Rollin L indirectly sold 41,100 shares of Symbotic Class A common stock for roughly $3.45 million in several transactions. The same day, related trusts redeemed Symbotic Holdings Units for Class A shares and sold a portion of those shares. Separately, Symbotic reported Q1 FY2026 results showing a revenue beat but profit short of estimates, while research and balance-sheet commentary point to a company with cash exceeding debt and forecasted revenue growth.

Key Points

  • Insider-related activity: Spouse of director Ford Rollin L indirectly sold 41,100 Class A shares on February 11, 2026, in multiple transactions totaling approximately $3.45 million.
  • Trust transactions and corporate housekeeping: Trusts tied to the same spouse redeemed 60,000 Symbotic Holdings Units for Class A shares, sold 20,000 of those shares, and Symbotic Holdings canceled the redeemed units while the issuer retired 60,000 Class V-1 shares for no consideration.
  • Financial and market context: Symbotic is trading at $54.95 with a $33.19 billion market cap, a 103% one-year return, a cash-heavy balance sheet relative to debt, an expected move to profitability this year, and consensus revenue growth of 23%.

An indirect sale tied to a director of Symbotic Inc. NASDAQ:SYM occurred on February 11, 2026, when the spouse of director Ford Rollin L disposed of 41,100 shares of Class A Common Stock for about $3.45 million. The transactions were executed across multiple trades with execution prices spanning $56.6347 to $59.1269.

On the same date, trusts connected with Ford's spouse completed a redemption of 60,000 Symbotic Holdings Units in exchange for 60,000 shares of Class A Common Stock. Those trusts subsequently sold 20,000 of the newly issued Class A shares.

In connection with that stock redemption, Symbotic Holdings proceeded to cancel the redeemed Symbotic Holdings Units. The issuer also canceled and retired for no consideration the 60,000 redeemed shares of Class V-1 Common Stock.

Market data at the time shows Symbotic trading at $54.95 with a market capitalization of $33.19 billion. Over the trailing 12 months the stock has returned 103%, despite experiencing recent volatility. Analysis from InvestingPro indicates the shares are currently trading below their calculated Fair Value.

InvestingPro also highlights Symbotic's balance-sheet posture, stating the company carries more cash than debt. The platform notes this liquidity position as a factor that could support future growth. Analysts cited by InvestingPro expect Symbotic to reach profitability within the current year, and project revenue growth of 23%.

Financial results disclosed for the first quarter of fiscal 2026 were mixed. Symbotic reported earnings per share of $0.02, falling short of the $0.08 consensus estimate. Revenue for the quarter measured $630 million, above the expected $622.58 million.

Meanwhile, DA Davidson revised its price target on Symbotic to $57 from $53 while retaining a Neutral rating. The firm attributed the target change to expectations for accelerated organic sales growth through fiscal 2027.

These developments - the insider-linked transactions, the unit redemptions and cancellations, the company's reported quarter and analyst target change - together form the latest public picture of Symbotic's stockholder activity and near-term operating outlook.

Risks

  • Profitability risk: Reported EPS of $0.02 in Q1 FY2026 missed the $0.08 estimate, signaling execution or margin pressures that could affect near-term earnings - this impacts investors in equity and sectors sensitive to margin improvement.
  • Market valuation and volatility: Although the stock is up 103% year-over-year, recent volatility and InvestingPro's view that the shares trade below Fair Value create uncertainty about near-term price direction - this affects equity market participants and portfolio managers.
  • Concentration of insider activity: The sizeable sale and related unit redemptions tied to a director's spouse introduce potential perception risk among shareholders regarding insider liquidity - relevant to corporate governance observers and institutional investors.

More from Insider Trading

Spyre Therapeutics CFO Disposes $370K in Stock, Exercises Options Same Day as Trial Timelines Accelerate Apr 3, 2026 Fold Holdings CEO completes modest stock sale to cover RSU tax obligations Apr 3, 2026 Spyre Therapeutics CEO Executes $739,912 Stock Sale as Trials Accelerate Apr 3, 2026 Spyre Therapeutics CMO Sells Shares, Exercises Options as Trials Accelerate Apr 3, 2026 Fold CFO Sells Small Stake to Meet Tax Withholding as Company Faces Revenue Shortfall Apr 3, 2026